Upcoming Dividend • Jun 23
Upcoming dividend of ر.س2.00 per share Eligible shareholders must have bought the stock before 30 June 2026. Payment date: 14 July 2026. Payout ratio is a comfortable 40% but the company is not cash flow positive. Trailing yield: 2.7%. Lower than top quartile of Saudi dividend payers (5.9%). In line with average of industry peers (2.7%). Announcement • Jun 05
Alf Meem Yaa for Medical Supplies and Equipment Company, Annual General Meeting, Jun 29, 2026 Alf Meem Yaa for Medical Supplies and Equipment Company, Annual General Meeting, Jun 29, 2026, at 19:00 Arab Standard Time. Location: jeddah Saudi Arabia Reported Earnings • Apr 08
Full year 2025 earnings released: EPS: ر.س5.00 (vs ر.س6.49 in FY 2024) Full year 2025 results: EPS: ر.س5.00 (down from ر.س6.49 in FY 2024). Revenue: ر.س305.0m (up 23% from FY 2024). Net income: ر.س35.0m (down 23% from FY 2024). Profit margin: 12% (down from 18% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Mar 16
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ر.س106, the stock trades at a trailing P/E ratio of 15.9x. Average trailing P/E is 20x in the Healthcare industry in Saudi Arabia. Total returns to shareholders of 198% over the past three years. New Risk • Mar 09
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. Cash payout ratio: 157% Dividend yield: 2.3% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.2% average weekly change). High level of non-cash earnings (25% accrual ratio). Minor Risk Dividend is not well covered by cash flows (157% cash payout ratio). New Risk • Feb 18
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Saudi stocks, typically moving 5.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (25% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (5.5% average weekly change). Buy Or Sell Opportunity • Dec 29
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 21% to ر.س94.90. The fair value is estimated to be ر.س119, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 20%. Valuation Update With 7 Day Price Move • Sep 22
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ر.س122, the stock trades at a trailing P/E ratio of 18.3x. Average forward P/E is 20x in the Healthcare industry in Saudi Arabia. Total returns to shareholders of 214% over the past three years. New Risk • Sep 18
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Saudi stocks, typically moving 7.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.6% average weekly change). High level of non-cash earnings (25% accrual ratio). Reported Earnings • Sep 05
Second quarter 2025 earnings released: EPS: ر.س1.19 (vs ر.س1.94 in 2Q 2024) Second quarter 2025 results: EPS: ر.س1.19 (down from ر.س1.94 in 2Q 2024). Revenue: ر.س68.1m (up 25% from 2Q 2024). Net income: ر.س8.31m (down 39% from 2Q 2024). Profit margin: 12% (down from 25% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Healthcare industry in Saudi Arabia. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 38% per year, which means it is tracking significantly ahead of earnings growth. Upcoming Dividend • May 19
Upcoming dividend of ر.س2.00 per share Eligible shareholders must have bought the stock before 26 May 2025. Payment date: 11 June 2025. Payout ratio is a comfortable 31% but the company is not cash flow positive. Trailing yield: 1.8%. Lower than top quartile of Saudi dividend payers (5.1%). In line with average of industry peers (1.8%). Valuation Update With 7 Day Price Move • May 12
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ر.س102, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 25x in the Healthcare industry in Saudi Arabia. Total returns to shareholders of 120% over the past three years. Announcement • May 05
Alf Meem Yaa for Medical Supplies and Equipment Company, Annual General Meeting, May 25, 2025 Alf Meem Yaa for Medical Supplies and Equipment Company, Annual General Meeting, May 25, 2025, at 19:30 Arab Standard Time. Location: jeddah Saudi Arabia New Risk • Mar 17
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (37% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (5.3% average weekly change). Valuation Update With 7 Day Price Move • Feb 27
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ر.س147, the stock trades at a trailing P/E ratio of 27.1x. Average trailing P/E is 30x in the Healthcare industry in Saudi Arabia. Total returns to shareholders of 181% over the past three years. New Risk • Dec 03
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Saudi stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (37% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (6.1% average weekly change). Valuation Update With 7 Day Price Move • Nov 07
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ر.س92.80, the stock trades at a trailing P/E ratio of 17.1x. Average trailing P/E is 32x in the Healthcare industry in Saudi Arabia. Total returns to shareholders of 112% over the past year. Announcement • Jun 26
Ame Company for Medical Supplies Approves Dividend Distribution for the Year 2023. Payable July 3, 2024 Ame Company For Medical Supplies announced Approval of the Board of Directors recommendation to distribute cash dividends to shareholders for the year 2023 at the rate of SAR 2 per share, which represents 20% of the nominal value of the share, with a total amount of SAR 14,000,000, provided that the eligibility is for shareholders who own shares at the end of trading on the day of the meeting. The General Assembly and those registered in the company's shareholder register with the Securities Depository Center Company (Depository Center) at the end of the second trading day following the maturity date, and the distribution of profits shall begin on Wednesday July 3, 2024. Announcement • May 31
Ame Company For Medical Supplies, Annual General Meeting, Jun 23, 2024 Ame Company For Medical Supplies, Annual General Meeting, Jun 23, 2024, at 18:30 Arab Standard Time. Location: jeddah Saudi Arabia Board Change • Nov 16
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Jun 23
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. 
